Exclusive biopharma, health policy, and life science analysis. Start your 30-day free trial today.

Catch up on the latest must-read coverage and analysis

advertisement

Most Popular

Tracking an FDA advisory panel meeting on Covid-19 vaccines and boosters
A new crop of companies is reshaping the health data economy
Many Medicare Part D beneficiaries don’t fill prescriptions for high-priced medicines
Report: U.S. nursing home care is ineffective, inefficient, inequitable, fragmented, and unsustainable
Virtual reality in medicine is garnering more investment. Will the health care system buy in?

Many Medicare Part D beneficiaries don’t fill prescriptions for high-priced medicines
Colombian government faces calls to issue compulsory license for Pfizer’s Covid-19 pill
The biotech scorecard for the second quarter: 21 stock-moving events to watch

advertisement

Events

A Conversation with the STAT Madness Crowd Favorite Apr. 20, 2022
Battle scars: The journey from lab to patient’s bedside May. 03, 2022
2022 STAT Health Tech Summit May. 24, 2022

See More Events

STAT Reports

Deep-dive reports into the breakthroughs that are revolutionizing health care.

Continuous glucose monitoring: how it’s advancing diabetes care
The ‘shroom boom’: The meteoric rise of the psychedelic medicine industry
2021 Update: Ranking biotech’s top venture capital firms

See More Reports